EN

API

Deferasirox

KDMF APIs

Deferasirox

Deferasirox basic information

Korean name

데페라시록스

Category

Other metabolic drugs

CAS No.

201530-41-8

KDMF registration No.

수2816-1ND(2)

Manufacturer

Mylan Laboratories Limitted

Specification

In-house

Product information

Deferasirox product information

IUPAC Name

4-[bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid

Synonyms

Deferasirox Deferasiroxum

Description

Deferasirox is an iron chelator and the first oral medication FDA approved for chronic iron overload in patients receiving long term blood transfusions.

Certificate of Analysis

If you need more information, please contact us.

If you need additional documents such as specifications or certificates of analysis, please request them together with your inquiry. Our team will review and reply. (02-579-1056 · ace@acebiopharm.com)